Health knowledge made personal
Join this community!
› Share page:
Search posts:

Identification of Renal Cell Carcinoma Biomarkers

Posted May 14 2009 5:00pm

Description of Invention:
This invention describes the identification of potential renal cancer biomarkers which could be utilized in the development of a renal cancer diagnostics. The invention identified cancer protein biomarkers from clinically relevant samples including peripheral blood and fresh frozen tissues. Vast availability of fresh frozen tissues and peripheral blood specimens that are easily obtained could lead to clinical tests amenable to therapeutic, prognostic and even early screening tests for renal cell carcinoma and other malignancies.

Renal cell carcinoma diagnostics, therapeutics and prognostics.

Josip Blonder (NCI)

Patent Status:
HHS, Reference No. E-317-2008/0
PCT, Application No. PCT/US2009/037855 filed 20 Mar 2009

Licensing Status:
Available for licensing.

Collaborative Research Opportunity:
The National Cancer Institute Laboratory of Proteomics and Analytical Technologies is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize diagnostic, therapeutic and prognostic cancer biomarkers from clinical specimens. Please contact John D. Hewes, Ph.D. at 301-435-3121 or for more information.

Cancer - Diagnostics

For Additional Information Please Contact:
Betty Tong Ph.D.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Phone: 301-594-6565
Fax: 301-402-0220

Ref No: 1949

Updated: 05/2009

Post a comment
Write a comment:

Related Searches